FDA inspection
Agilera Pharma AS: FDA inspection ending Mar 24, 2023
FDA inspection 1203671 · No Action Indicated (NAI) · Kjeller
Key facts
| Inspection ID | 1203671 |
|---|---|
| Firm | Agilera Pharma AS |
| FEI number | 3008160514 |
| Address | Instituttveien 18 |
| City | Kjeller |
| Country | Norway |
| Fiscal year | 2023 |
| Inspection end date | Mar 24, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data